{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,7]],"date-time":"2024-09-07T07:27:40Z","timestamp":1725694060354},"publisher-location":"Vienna","reference-count":65,"publisher":"Springer Vienna","isbn-type":[{"type":"print","value":"9783211828915"},{"type":"electronic","value":"9783709174944"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1996]]},"DOI":"10.1007\/978-3-7091-7494-4_4","type":"book-chapter","created":{"date-parts":[[2012,7,28]],"date-time":"2012-07-28T20:54:42Z","timestamp":1343508882000},"page":"29-43","source":"Crossref","is-referenced-by-count":0,"title":["The pharmacology of B-type selective monoamine oxidase inhibitors; milestones in (\u2212)-deprenyl research"],"prefix":"10.1007","author":[{"given":"K.","family":"Magyar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Szende","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Lengyel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Tekes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"4_CR1","doi-asserted-by":"crossref","first-page":"4042","DOI":"10.1523\/JNEUROSCI.13-09-04042.1993","volume":"13","author":"KS Ansari","year":"1993","unstructured":"Ansari KS, Tatton WG, Yu PH, Kruck TPA (1993) Rescue of axotomised immature rat facial motoneurons by R(\u2212)-deprenyl: stereospecificity and independence from monoamine oxidase inhibition. J Neurosci 13: 4042\u20134053","journal-title":"J Neurosci"},{"key":"4_CR2","first-page":"1646","volume":"19","author":"AJ Barber","year":"1993","unstructured":"Barber AJ, Paterson lA, Gelowitz DL, Voll CL (1993) Deprenyl protects rat hippocampal pyramidal cells from ischaemic insult. Soc Neurosci Abstr 19: P1646","journal-title":"Soc Neurosci Abstr"},{"key":"4_CR3","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/0301-0082(94)90081-7","volume":"42","author":"MD Berry","year":"1994","unstructured":"Berry MD, Juorio AV, Paterson IA (1994) The functional role of monoamine oxidases A and B in the mammalian central nervous system. Prog Neurobiol 42: 375\u2013391","journal-title":"Prog Neurobiol"},{"key":"4_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0031-6989(88)80574-5","volume":"20","author":"B Bertocci","year":"1988","unstructured":"Bertocci B, Gill G, Da Prada M (1988) Prevention of the DSP-4-induced noradrenergic neurotoxicity by irreversible, not by reversible MAO-B inhibitors. Pharmacol Res Commun 20: 131\u2013132","journal-title":"Pharmacol Res Commun"},{"key":"4_CR5","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1007\/BF01253131","volume":"36","author":"W Birkmayer","year":"1975","unstructured":"Birkmayer W, Riederer P, Youdim MBH, Linauer W (1975) The potentiation of the antiakinetic effect of L-dopa treatment by an inhibitor of MAO-B, l-deprenyl. J Neural Transm 36: 303\u2013336","journal-title":"J Neural Transm"},{"key":"4_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/BF01245973","volume":"64","author":"W Birkmayer","year":"1985","unstructured":"Birkmayer W, Knoll J, Riederer P, Youdim MBH, Hars V, Martin J (1985) Increased life expectancy resulting from addition of l-deprenyl to Madopar\u00ae treatment in Parkinson\u2019s disease: a long-term study. J Neural Transm 64: 113\u2013128","journal-title":"J Neural Transm"},{"key":"4_CR7","first-page":"217","volume-title":"Amphetamines and related compounds","author":"BB Brodie","year":"1970","unstructured":"Brodie BB, Cho AK, Gessa GL (1970) Possible role of p-hydroxynorephedrine in the depletion of norepinephrine induced by d-amphetamine and in tolerance to this drug. In: Costa E, Garattini S (eds) Amphetamines and related compounds. Raven Press, New York, pp 217\u2013230"},{"key":"4_CR8","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/0024-3205(91)90466-O","volume":"48","author":"MC Carrillo","year":"1991","unstructured":"Carrillo MC, Kanai S, Nokubo M, Kitani K (1991) (\u2212)-Deprenyl induces activities of both superoxide dismutase and catalase but not of glutathione peroxidase in the striatum of young male rats. Life Sci 48: 517\u2013521","journal-title":"Life Sci"},{"key":"4_CR9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/BF01250378","volume":"86","author":"A Clow","year":"1991","unstructured":"Clow A, Hussain T, Glover V, Sandler M, Dexter DT, Walker M (1991) (\u2212)-deprenyl can induce soluble superoxide dismutase in rat striata. J Neural Transm 86: 77\u201380","journal-title":"J Neural Transm"},{"key":"4_CR10","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1017\/S0317167100032492","volume":"18","author":"M Prada Da","year":"1991","unstructured":"Da Prada M (1991) New approaches to the treatment of age-related brain disorders. Can J Neurol Sci 18: 384\u2013386","journal-title":"Can J Neurol Sci"},{"key":"4_CR11","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1007\/BF01946641","volume":"40","author":"M Prada Da","year":"1984","unstructured":"Da Prada M, Keller HH, Pieri L, Kettler R, Haefely WE (1984) The pharmacology of Parkinson\u2019s disease: basic aspects and recent advances. Experiencia 40: 1165\u20131172","journal-title":"Experiencia"},{"key":"4_CR12","first-page":"279","volume":"29","author":"M Prada Da","year":"1990","unstructured":"Da Prada M, Kettler R, Keller HH, Cesura AM, Richards JG, Marti JS (1990) From moclobemide to Ro 19-6327 and Ro 41-1049: the development of a new class of reversible, selective MAO-A and MAO-B inhibitors. J Neural Transm [Suppl] 29: 279\u2013292","journal-title":"J Neural Transm [Suppl]"},{"key":"4_CR13","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1111\/j.1600-0447.1988.tb06412.x","volume":"78","author":"W Danielczyk","year":"1988","unstructured":"Danielczyk W, Streifler M, Konradi C, Riederer P, Moll G (1988) MAO-B activity and the psychopathology of Parkinson\u2019s disease, senile dementia and multiinfarction dementia. Acta Psychiatr Scand 78: 730\u2013736","journal-title":"Acta Psychiatr Scand"},{"key":"4_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/BF00426954","volume":"57","author":"JD Elsworth","year":"1978","unstructured":"Elsworth JD, Glover V, Reynolds GP, Sandler M, Lees AJ, Phuapradit P, Shaw KM, Stern GM, Kumar P (1978) Deprenyl administration in man; a selective monoamine oxidase B inhibitor without the \u201cCheese effect\u201d. Psychopharmacology 57: 33\u201338","journal-title":"Psychopharmacology"},{"key":"4_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0014-2999(90)90672-S","volume":"184","author":"KT Finnegan","year":"1990","unstructured":"Finnegan KT, Skratt JS, Irwin I, DeLanney LE, Langston JW (1990) Protection against DSP-4-induced neurotoxicity by deprenyl is not related to its inhibition of MAO-B. Eur J Pharmacol 184: 119\u2013126","journal-title":"Eur J Pharmacol"},{"key":"4_CR16","doi-asserted-by":"publisher","first-page":"1534","DOI":"10.1111\/j.1471-4159.1983.tb08123.x","volume":"40","author":"CJ Fowler","year":"1983","unstructured":"Fowler CJ, Strolin-Benedetti M (1983) The metabolism of dopamine by both forms of monoamine oxidase in the rat brain and its inhibition by cimaxatone. J Neurochem 40: 1534\u20131541","journal-title":"J Neurochem"},{"key":"4_CR17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/0014-2999(87)90420-1","volume":"141","author":"C Gibson","year":"1987","unstructured":"Gibson CJ (1987) Inhibition of MAO-B, but not MAO-A blocks DSP-4 toxicity on central NE neurons. Eur J Pharmacol 141: 135\u2013138","journal-title":"Eur J Pharmacol"},{"key":"4_CR18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1002\/cbf.290040203","volume":"4","author":"V Glover","year":"1986","unstructured":"Glover V, Sandler M (1986) Clinical chemistry of monoamine oxidase. Cell Biochem Func 4: 89\u201397","journal-title":"Cell Biochem Func"},{"key":"4_CR19","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/265080a0","volume":"265","author":"V Glover","year":"1977","unstructured":"Glover V, Sandler M, Owen F, Riley GJ (1977) Dopamine is a monoamine oxidase B substrate in man. Nature 265: 80\u201381","journal-title":"Nature"},{"key":"4_CR20","unstructured":"Glover V, Gibb C, Sandler M (1986) The role of MAO in MPTP toxicity \u2014 a review. J Neural Transm [Suppl] 65\u201376"},{"key":"4_CR21","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/0304-4165(65)90412-5","volume":"107","author":"M Goldstein","year":"1965","unstructured":"Goldstein M, Anagnoste B (1965) The conversion in vivo of d-amphetamine to (+)-phydroxynorephedrine. Biochim Biophys Acta 107: 166\u2013168","journal-title":"Biochim Biophys Acta"},{"key":"4_CR22","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/0014-2999(84)90487-4","volume":"103","author":"H Hallman","year":"1984","unstructured":"Hallman H, Jonsson G (1984) Pharmacological modifications of the neurotoxic action of the noradrenaline neurotoxin DSP-4 on central noradrenaline neurons. Eur J Pharmacol 103: 269\u2013278","journal-title":"Eur J Pharmacol"},{"key":"4_CR23","first-page":"297","volume":"31","author":"LG Harsing","year":"1979","unstructured":"Harsing LG, Magyar K, Tekes K, Vizi ES, Knoll J (1979) Inhibition by deprenyl of dopamine uptake in rat striatum: a possible correlation between dopamine uptake and acethylcholine release inhibition. Pol J Pharmacol Pharm 31: 297\u2013307","journal-title":"Pol J Pharmacol Pharm"},{"key":"4_CR24","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1073\/pnas.82.7.2173","volume":"82","author":"JA Javitch","year":"1985","unstructured":"Javitch JA, d\u2019Amato RJ, Strittmatter SM, Snyder SH (1985) Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-l,2,3,6-tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity. Proc Natl Acad Sci USA 82: 2173\u20132177","journal-title":"Proc Natl Acad Sci USA"},{"key":"4_CR25","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/0006-2952(68)90066-X","volume":"17","author":"J Johnston","year":"1968","unstructured":"Johnston JP (1968) Some observations upon a new inhibitor of monoamine oxidase in brain tissue. Biochem Pharmacol 17: 1285\u20131297","journal-title":"Biochem Pharmacol"},{"key":"4_CR26","first-page":"253","volume-title":"Enzyme activated irreversible inhibitors","author":"J Knoll","year":"1978","unstructured":"Knoll J (1978) The pharmacology of selective irreversible monoamine oxidase inhibitors. In: Seiler N, Jung MJ, Koch-Weser J (eds) Enzyme activated irreversible inhibitors. Elsevier-North Holland, Amsterdam, pp 253\u2013269"},{"key":"4_CR27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1600-0404.1983.tb01517.x","volume":"95","author":"J Knoll","year":"1983","unstructured":"Knoll J (1983) (\u2212)-Deprenyl ((\u2212)-deprenyl): the history of its development and pharmacological action. Acta Neurol Scand [Suppl] 95: 57\u201380","journal-title":"Acta Neurol Scand [Suppl]"},{"key":"4_CR28","unstructured":"Knoll J (1985) Striatal dopamine, aging and deprenyl. In: Borsy J, Kerecsen L, Gyorgy L (eds) Proc 4th Cong Hung Pharmacol Soc Budapest 3: 7\u201325"},{"key":"4_CR29","first-page":"45","volume":"25","author":"J Knoll","year":"1987","unstructured":"Knoll J (1987) R-(\u2212)-Deprenyl ((\u2212)-deprenyl, Mogervan\u00ae) facilitates the activity of the nigro-striatal dopaminergic neuron. J Neural Transm 25: 45\u201366","journal-title":"J Neural Transm"},{"key":"4_CR30","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/0047-6374(88)90128-5","volume":"46","author":"J Knoll","year":"1988","unstructured":"Knoll J (1988) The striatal dopamine dependency of life span in male rats. Longevity study with (\u2212)-deprenyl. Mech Aging Dev 46: 237\u2013262","journal-title":"Mech Aging Dev"},{"key":"4_CR31","first-page":"393","volume":"5","author":"J Knoll","year":"1972","unstructured":"Knoll J, Magyar K (1972) Some puzzling pharmacological effects of monoamine oxidase inhibitors. Adv Biochem Psychopharmacol 5: 393\u2013408","journal-title":"Adv Biochem Psychopharmacol"},{"key":"4_CR32","first-page":"154","volume":"155","author":"J Knoll","year":"1965","unstructured":"Knoll J, Ecseri Z, Kelemen K, Nievel J, Knoll B (1965) Phenylisopropylmethylpropinylamine (E-250), and new spectrum psychic energizer. Arch Int Pharmacodyn Ther 155: 154\u2013164","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"4_CR33","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1002\/ijc.2910460322","volume":"46","author":"A Lad\u00e1nyi","year":"1990","unstructured":"Lad\u00e1nyi A, Tim\u00e1r J, Paku S, Moln\u00e1r G, Lapis K (1990) Selection and characterization of human melanoma lines with different liver-colonizing capacity. Int J Cancer 46: 456\u2013461","journal-title":"Int J Cancer"},{"key":"4_CR34","first-page":"221","volume":"41","author":"CT Lai","year":"1994","unstructured":"Lai CT, Zuo DM, Yu PH (1994) Is brain superoxide dismutase activity increased following chronic treatment with L-deprenyl? J Neural Transm 41: 221\u2013229","journal-title":"J Neural Transm"},{"key":"4_CR35","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1212\/WNL.40.9.1337","volume":"40","author":"W Landau","year":"1990","unstructured":"Landau WM (1990) Clinical neuromythology IX. Pyramid sale in the bucket shop: DATATOP bottoms out. Neurology 40: 1337\u20131339","journal-title":"Neurology"},{"issue":"[Suppl3]","key":"4_CR36","first-page":"61","volume":"40","author":"J Langston","year":"1980","unstructured":"Langston JW (1980) (\u2212)-deprenyl as neuroprotective therapy in Parkinson\u2019s disease: concepts and controversies. Neurology [Suppl3] 40: 61\u201366","journal-title":"Neurology"},{"key":"4_CR37","unstructured":"Magyar K (1991) Neuroprotective effect of deprenyl and p-fluor-deprenyl. Second Congress Paneuropean Society of Neurology, Vienna, p26"},{"key":"4_CR38","first-page":"125","volume-title":"Inhibitors of monoamine oxidase B","author":"K Magyar","year":"1992","unstructured":"Magyar K (1992) Pharmacology of monoamine oxidase type B inhibitors. In: Szelenyi I (ed) Inhibitors of monoamine oxidase B. Birkh\u00e4user, Basel, pp 125\u2013143"},{"key":"4_CR39","first-page":"167","volume":"41","author":"K Magyar","year":"1994","unstructured":"Magyar K (1994) Behaviour of (\u2212)-deprenyl and its analogues. J Neural Transm 41: 167\u2013175","journal-title":"J Neural Transm"},{"key":"4_CR40","first-page":"414","volume":"37","author":"K Magyar","year":"1970","unstructured":"Magyar K, Knoll J (1970) Effect of phenyl-isopropyl-methyl-propinylamine (deprenaline) on the subcellular distribution of 3H-noradrenaline. Acta Physiol Hung 37: p414","journal-title":"Acta Physiol Hung"},{"key":"4_CR41","first-page":"377","volume":"32","author":"K Magyar","year":"1967","unstructured":"Magyar K, Vizi ES, Ecseri Z, Knoll J (1967) Comparative pharmacological analysis of the optical isomers of phenyl-isopropyl-methyl-propinylamine (E-250). Acta Physiol Hung 32: 377\u2013387","journal-title":"Acta Physiol Hung"},{"key":"4_CR42","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0193-953X(18)30749-4","volume":"7","author":"DL Murphy","year":"1984","unstructured":"Murphy DL, Sunderland T, Cohen RM (1984) Monoamine oxidase-inhibiting antidepressants. Psychiat Clin North Am 7: 549\u2013562","journal-title":"Psychiat Clin North Am"},{"issue":"[Suppll]","key":"4_CR43","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1159\/000116350","volume":"26","author":"T Nagatsu","year":"1987","unstructured":"Nagatsu T, Hirata Y (1987) Inhibition of the tyrosine hydroxylase system by MPTP, 1-methyl-4-phenylpiridinium ion (MPP+) and the structurally related compounds in vitro and in vivo. Eur Neurol 26 [Suppll]: 11","journal-title":"Eur Neurol"},{"key":"4_CR44","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1016\/0006-291X(89)91371-5","volume":"161","author":"M Naoi","year":"1989","unstructured":"Naoi M, Matsuura S, Takahashi T, Nagatsu T (1989) An N-methyltransferase in human brain catalyses N-methylation of 1,2,3,4-tetrahydroisoquinoline into N-methyl1,2,3,4-tetrahydroisoquinoline, a precursor of a dopaminergic neurotoxin, N-methylisoquinolinium ion. Biochem Biophys Res Commun 161: 1213\u20131219","journal-title":"Biochem Biophys Res Commun"},{"key":"4_CR45","first-page":"173","volume":"16","author":"GP Reynolds","year":"1980","unstructured":"Reynolds GP, Riederer P, Rausch WD (1980) Dopamine metabolism in human brain: effects of monoamine oxidase inhibition in vitro by (\u2212)-deprenyl and (\u2212)tranylcypromine. J Neural Transm [Suppl] 16: 173\u2013178","journal-title":"J Neural Transm [Suppl]"},{"issue":"5","key":"4_CR46","first-page":"163","volume":"VIII","author":"A Ricci","year":"1992","unstructured":"Ricci A, Mancini M, Strocchi P, Bongrani S, Bronzetti E (1992) Deficits in cholinergic neurotransmission markers induced by ethylcholine mustard aziridinium (AF64A) in the rat hippocampus: sensitivity to treatment with the monoamine oxidase-B inhibitor l-deprenyl. Drugs Exp Clin Res VIII(5): 163\u2013171","journal-title":"Drugs Exp Clin Res"},{"key":"4_CR47","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1600-0404.1989.tb01781.x","volume":"126","author":"P Riederer","year":"1989","unstructured":"Riederer P, Konradi C, Hebenstreit G, Youdim MBH (1989) Neurochemical perspectives to the function of monoamine oxidase. Acta Neurol Scand 126: 41\u201345","journal-title":"Acta Neurol Scand"},{"issue":"[Suppl95]","key":"4_CR48","first-page":"5","volume":"68","author":"U Rinne","year":"1983","unstructured":"Rinne UK (1983) A new approach to the treatment of Parkinson\u2019s disease. Acta Neurol Scand [Suppl95] 68:5\u2013144","journal-title":"Acta Neurol Scand"},{"key":"4_CR49","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.2042-7158.1976.tb04659.x","volume":"28","author":"SB Ross","year":"1976","unstructured":"Ross SB, Renyi AL (1976) On the long-lasting inhibitory effect of N-(2-chloroethyl)-Nethyl-2-bromobenzylamine (DSP-4) on the active uptake of adrenaline. J Pharm Pharmacol 28:458\u2013459","journal-title":"J Pharm Pharmacol"},{"key":"4_CR50","first-page":"29","volume":"10","author":"SB Ross","year":"1973","unstructured":"Ross SB, Johansson JG, Lindborg B, Dahlbom R (1973) Cyclizing compounds. I. Tertiary N-(2-chloroethyl)-N-ethyl-2-haloalkylamine with adrenergic blocking actions. Acta Pharm Suec 10: 29\u201342","journal-title":"Acta Pharm Suec"},{"key":"4_CR51","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/0006-291X(84)90614-4","volume":"125","author":"JI Salach","year":"1984","unstructured":"Salach JI, Singer TP, Castagnoli N, Trevor A (1984) Oxidation of the neurotoxic amine 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by monoamine oxidases A and B and suicide inactivation of the enzymes by MPTP. Biochem Biophys Res Comm 125: 831\u2013835","journal-title":"Biochem Biophys Res Comm"},{"key":"4_CR52","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1136\/jnnp.43.11.1016","volume":"43","author":"M Schachter","year":"1980","unstructured":"Schachter M, Marsden CD, Parkes JD, Jenner P, Testa B (1980) Deprenyl in the management of response fluctuations in patients with Parkinson\u2019s disease on levodopa. J Neurol Neurosurg Psychiatry 43: 1016\u20131021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"4_CR53","first-page":"78","volume":"165","author":"SR Snyder","year":"1969","unstructured":"Snyder SR, Coyle JT (1969) Regional differences in 3H-norepinephrine and 3H-dopamine uptake into rat brain homogenates. J Pharmacol Exp Ther 165: 78\u201386","journal-title":"J Pharmacol Exp Ther"},{"key":"4_CR54","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/0006-2952(89)90198-6","volume":"38","author":"M Strolin-Benedetti","year":"1989","unstructured":"Strolin-Benedetti M, Dostert P (1989) Monoamine oxidase, brain ageing and degenerative diseases. Biochem Pharmacol 38: 555\u2013561","journal-title":"Biochem Pharmacol"},{"key":"4_CR55","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1002\/jnr.490300410","volume":"30","author":"WG Tatton","year":"1991","unstructured":"Tatton WG, Greenwood CE (1991) Rescue of dying neurons: a new action for deprenyl in MPTP parkinsonism. J Neurosci Res 30: 666\u2013672","journal-title":"J Neurosci Res"},{"key":"4_CR56","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1046\/j.1471-4159.1994.63041572.x","volume":"63","author":"WG Tatton","year":"1994","unstructured":"Tatton WG, Ju WYL, Holland DP, Tai C, Kwan M (1994) (\u2212)-Deprenyl reduces PC12 cell apoptosis by inducing new protein synthesis. J Neurochem 63: 1572\u20131575","journal-title":"J Neurochem"},{"key":"4_CR57","first-page":"653","volume":"40","author":"K Tekes","year":"1988","unstructured":"Tekes K, T\u00f3thfalusi L, Ga\u00e1l J, Magyar K (1988) Effect of MAO inhibitors on the uptake and metabolism of dopamine in rat and human brain. Pol J Pharmacol Pharm 40: 653\u2013658","journal-title":"Pol J Pharmacol Pharm"},{"key":"4_CR58","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1126\/science.2502843","volume":"245","author":"JW Tetrud","year":"1989","unstructured":"Tetrud JW, Langston JW (1989) The effect of deprenyl ((\u2212)-deprenyl) on the natural history of Parkinson\u2019s disease. Science 245: 519\u2013522","journal-title":"Science"},{"key":"4_CR59","first-page":"1","volume-title":"Biochemical and pharmacological aspects of depression","author":"K Tipton","year":"1989","unstructured":"Tipton KF (1989) In: Tipton KF, Youdim MBH (eds) Biochemical and pharmacological aspects of depression. Taylor & Francis, London, pp 1\u201324"},{"key":"4_CR60","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/S0074-7696(08)62312-8","volume":"68","author":"AH Wyllie","year":"1986","unstructured":"Wyllie AH, Kerr IFR, Currie AR (1986) Cell death: the significance of apoptosis. Int Rev Cytol 68: 251\u2013306","journal-title":"Int Rev Cytol"},{"key":"4_CR61","first-page":"127","volume":"45","author":"MBH Youdim","year":"1986","unstructured":"Youdim MBH, Finberg JPM (1986) MAO type B inhibitors as adjunct to L-dopa therapy. Adv Neurol 45: 127\u2013136","journal-title":"Adv Neurol"},{"key":"4_CR62","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1046\/j.1471-4159.1994.63051820.x","volume":"63","author":"PH Yu","year":"1994","unstructured":"Yu PH, Davis BA, Fang J, Boulton AA (1994) Neuroprotective effects of some monoamine oxidase-B inhibitors against DSP-4 induced noradrenaline depletion in the mouse hippocampus. J Neurochem 63: 1820\u20131828","journal-title":"J Neurochem"},{"key":"4_CR63","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0014-2999(80)90398-2","volume":"65","author":"LM Zieher","year":"1980","unstructured":"Zieher LM, Jaim-Etcheverry G (1980) Neurotoxicity of N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine (DSP-4) on noradrenergic neurons is mimicked by its cyclic aziridinium derivative. Eur J Pharmacol 65: 249\u2013256","journal-title":"Eur J Pharmacol"},{"key":"4_CR64","first-page":"211","volume":"31","author":"G Zsilla","year":"1982","unstructured":"Zsilla G, Knoll J (1982) The action of (\u2212)-deprenyl on monoamine turnover rate in rat brain. Adv Biochem Psychopharmacol 31: 211\u2013217","journal-title":"Adv Biochem Psychopharmacol"},{"key":"4_CR65","first-page":"117","volume":"11","author":"G Zsilla","year":"1983","unstructured":"Zsilla G, Barbaccia ML, Gandolfi O, Knoll J, Costa E (1983) (\u2212)-Deprenyl, a selective MAO-B inhibitor increased 3H-imipramine binding and decreased beta-adrenergic receptor function. Eur J Pharmacol 11: 117","journal-title":"Eur J Pharmacol"}],"container-title":["Deprenyl \u2014 Past and Future"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-7091-7494-4_4.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T09:36:24Z","timestamp":1606124184000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-7091-7494-4_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996]]},"ISBN":["9783211828915","9783709174944"],"references-count":65,"URL":"https:\/\/doi.org\/10.1007\/978-3-7091-7494-4_4","relation":{},"subject":[],"published":{"date-parts":[[1996]]}}}